The Senate passed a massive opioid bill 99-1, but public health experts and first responders are concerned it won’t do enough to stop the crisis; pharmaceutical companies with manufacturing plants in North Carolina, South Carolina, and Virginia put emergency plans in place last week as Hurricane Florence bore down to avoid shortages of drugs and vaccines; the cannabis industry is booming, and one of the fastest growing group of users are people over age 50.
The Senate passed a massive opioid bill 99-1, but public health experts and first responders are concerned it won’t do enough to stop the crisis, Politico reported. It does little to address the severe nationwide shortage of treatment beds for rehab or to encourage more doctors to prescribe medication to treat substance use disorder, which requires special training and licensing. The bills create new grants and demonstrations to test new treatment programs, but there is no permanent funding solution attached.
Pharmaceutical companies with manufacturing plants in North Carolina, South Carolina, and Virginia put emergency plans in place last week as Hurricane Florence bore down to avoid shortages of drugs and vaccines, STAT reported. GlaxoSmithKline closed a plant that makes asthma inhalers; Novartis shut down a facility that manufactures oral-dosage generic drugs; and Pfizer and Merck scaled back or closed operations at multiple North Carolina facilities. Besides the safety of employees, companies also sought to avoid the loss of drugs that would have hurt corporations’ bottom lines.
As more states legalize marijuana for medical or recreational use—30 states plus the District of Columbia to date—the cannabis industry is booming, and one of the fastest growing group of users are people over age 50, especially those 65 and older, Kaiser Health News reported. Kaiser profiled a retirement community in California where a medical marijuana dispensary sends a free shuttle bus to pick up senior citizens seeking relief from pain and other conditions.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Tech Advances for Ocular Conditions Could Revolutionize Care
March 5th 2025Advancements in ocular technology, teleretinal imaging, and low-vision aids, including artificial intelligence-powered smart glasses, were highlighted in research posters at the Southeastern Congress of Optometry 2025.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Facilitators of and Barriers to Medicaid Investment in Electronic Consultation Services
March 5th 2025In this qualitative investigation, leaders of Medicaid managed care plans were interviewed to identify facilitators of and barriers to electronic consultation for specialty care delivery.
Read More